Cannabis Science Inc (fka CBIS)

[newmedman]

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangement of Certain
Officers.

With the Special Board Meeting held on July 10, 2009, the Board has received
and has accepted the resignation of Steven W. Kubby as a member of the
Board of Directors.

The Board has received and has accepted the resignations of Ray Carr, Mary
Ruwart and Lee Wrights from all previous positions held in the Company.

The Board hereby authorizes an internal investigation and review by counsel
of Mr. Kubby's apparently fraudulent activities using the position he held
as President & CEO as his authority to carry out these activities that
damaged the Company and its shareholder value, including but not limited to:

a. Mr. Kubby's inappropriate and unauthorized signing of a financial
and share agreement with Mary Ruwart and Ray Carr, which were not disclosed
to nor approved by the Board, using unauthorized company shares as collateral
or consideration for his personal gain.

b. Mr. Kubby's inappropriate and unauthorized signing of a financial
and share agreement with a private party, which was not disclosed to nor
approved by the Board, using unathorized company shares as collateral or
consideration for his personal gain.


c. Mr. Kubby's inappropriate and unauthorized signing of a financial
and share agreement with an independent financial group, which was not
disclosed to nor approved by the Board, which could have significantly
diluted and damaged shareholder interest.

d. Mr. Kubby's inappropriate and unauthorized acceptance of funds
into a company account to which he had blocked and removed access by other
officers and directors without approval or resolution.


e. Mr. Kubby's apparent inappropriate and unauthorized distribution of
Company funds for his personal gain, while leaving essential obligations of
the Company unmet.

f. Mr. Kubby's libelous accusation against the Company's Directors and
a key consultant, while misrepresenting his own actions to the public and
the media in a manner injurious to the Company's interests.
http://www.sec.gov/Archives/edgar/data/1024626/000110270909000013/cbis-8k502july14.txt